AXIM Biotechnologies Receives Medical Device Manufacturing License [Yahoo! Finance]
Axim Biotechnologies, Inc (AXIM)
NASDAQ:AMEX Investor Relations:
aximbiotech.com
Company Research
Source: Yahoo! Finance
SAN DIEGO, CA - ( NewMediaWire ) - May 29, 2024 - AXIM Biotechnologies, Inc OTCQB: AXIM ) ("AXIM Biotech," "AXIM" or "the Company"), an international healthcare diagnostic solutions development company, today announced that it received a Medical Device Manufacturing License from State of California Department of Public Heath Food and Drug Branch. The license allows AXIM to manufacture medical devices, such as its ophthalmological diagnostic assays, for either commercial or clinical use. The Medical Device Manufacturing License broadly allows companies to manufacture any type of medical device, further enabling AXIM the ability to develop novel diagnostic solutions for use in clinical studies as well as for commercial use, pending any additional regulatory approval requirements. AXIM currently has two FDA-cleared ocular diagnostic assays, its T-POC TOTAL IgE Immunoassay and T-POC LACTOFERRIN Immunoassay Kits. Both are being marketed through the Company's commercialization partner Ve
Show less
Read more
Impact Snapshot
Event Time:
AXIM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXIM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXIM alerts
High impacting Axim Biotechnologies, Inc news events
Weekly update
A roundup of the hottest topics
AXIM
Sec Filings
- 5/22/24 - Form 10-Q/A
- 5/20/24 - Form 10-Q
- 5/15/24 - Form NT
- AXIM's page on the SEC website